- CD44v6 expression is associated with a poor prognosis in Chinese hepatocellular carcinoma patients: A meta-analysis
Yong Fu et al, 2015, Clinics and Research in Hepatology and Gastroenterology CrossRef - Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
Yangkun Luo et al, 2016, Cancer Cell International CrossRef - Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival
Zhao-Shan Niu, 2015, World Journal of Hepatology CrossRef - CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virusāpositive patients with resected hepatocellular carcinoma
Anna Kakehashi et al, 2016, Cancer Science CrossRef - New trends in guided nanotherapies for digestive cancers: A systematic review
Elisabete Fernandes et al, 2015, Journal of Controlled Release CrossRef